Biomarkers

Three Exciting Dupuytren Updates and a Public Seminar
By: Charles Eaton
Oct 30, 2022

I want to share three exciting Dupuytren updates with you this Halloween. The first update is the growing use of artificial intelligence (AI) in medical research. The term “Artificial Intelligence” is a little misleading. Today, AI is about computerized pattern-matching rather than thinking and consciousness, but it’s still amazing. The pumpkin pictures above are all […]

Read more ›
Disease Modifying AntiDupuytren Drugs
On: Sep 7, 2022
By: Charles Eaton

The path to a Dupuytren cure is connected to the story of drugs for rheumatoid arthritis. The evolution of rheumatoid drug treatment dates back centuries, based on guesswork and trial and error. During this time, hundreds of rheumatoid “cures” were recommended – herbs, diets, bedrest, baths, special clothing, radioactive exposure, special jewelry, injections of arsenic […]

Read more ›
August is National Make a Will month
On: Aug 25, 2022
By: Charles Eaton

Here at the Dupuytren Research Group, we’re planning for the future. Dupuytren spans generations. Our work centers on families. That’s why it’s the perfect time to be reminded that August is National Make a Will Month. Wills are essential regardless of wealth. They are about you – protecting your loved ones, avoiding family feuds, and preventing the government’s […]

Read more ›
Happy Holidays from DRG
On: Dec 22, 2021
By: Charles Eaton

When we all lend a hand helping the community we improve everyone’s quality of life. Best wishes in this holiday season from the Dupuytren Research Group

Read more ›
Don’t forget Dupuytren on Giving Tuesday!
On: Nov 29, 2021
By: Charles Eaton

The Dupuytren Research Group’s work is supported entirely by your charitable gifts. Thanks to you, our blood test pilot study has completed blood sample collection, and analysis is underway. This is the first step toward a large research study to develop a Dupuytren blood test. We’ve made it this far because of the Dupuytren community’s […]

Read more ›
Petition the NIH to Fund Dupuytren Research
On: Jun 22, 2021
By: Charles Eaton

If you are affected by Dupuytren disease, you know Dupuytren isn’t going away by itself. We must work together for a future without Dupuytren disease. Right now, there is no US federal Dupuytren-specific research funding. Help change this now! Sign this petition to tell the National Institutes of Health Dupuytren Research Funding Matters! https://www.ipetitions.com/petition/we-support-the-need-for-dupuytren-disease-research

Read more ›
Happy Holidays from the Dupuytren Research Group!

The Dupuytren Research Group is headquartered in sandy West Palm Beach Florida. This is our area’s most visible celebration of the season: SandiLand, featuring the world’s only 35-foot, 700-ton holiday sand tree. It’s a large accomplishment. It took a lot of planning and many people working together – just like the research the Dupuytren Research […]

Read more ›
2020 IDDB Progress and Findings
On: Apr 23, 2020
By: Charles Eaton

2020 IDDB Progress and Findings The International Dupuytren Data Bank is now in its fifth year with 4465 enrollees from 48 countries. There’s now enough data to begin looking for trends and new insights. We’ve begun collecting blood samples from select enrollees for the Dupuytren Blood Biomarker Pilot Study. Blood sample collection is on hold until […]

Read more ›